Application Sponsors
ANDA 209970 | TEVA PHARMS USA INC | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | CAPSULE, EXTENDED RELEASE;ORAL | 375MG | 0 | MESALAMINE | MESALAMINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2018-07-11 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
TEVA PHARMS USA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 209970
[companyName] => TEVA PHARMS USA INC
[docInserts] => ["",""]
[products] => [{"drugName":"MESALAMINE","activeIngredients":"MESALAMINE","strength":"375MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/11\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-07-11
)
)